Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
Quabodepistat by Otsuka Pharmaceutical for Pulmonary Tuberculosis: Likelihood of Approval
Quabodepistat is under clinical development by Otsuka Pharmaceutical and currently in Phase II for Pulmonary Tuberculosis. According to GlobalData, Phase...